Asymptomatic reactivation of JC virus in patients treated with natalizumab

N Engl J Med. 2009 Dec 17;361(25):2487-8; author reply 2489-90. doi: 10.1056/NEJMc0909622.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Humans
  • Integrin alpha4 / immunology
  • JC Virus / isolation & purification*
  • JC Virus / physiology
  • Leukocytes, Mononuclear / virology
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy*
  • Natalizumab
  • Viral Load
  • Viremia
  • Virus Activation / drug effects*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Natalizumab
  • Integrin alpha4